No Association of Multiple Sclerosis with C9orf72 Hexanucleotide Repeat Size in an Austrian Cohort

• Published in: International journal of molecular sciences Vol. 24; no. 14; p. 11254
• Main Authors: König, Theresa, Leutmezer, Fritz, Berger, Thomas, Zimprich, Alexander, Schmied, Christiane, Stögmann, Elisabeth, Zrzavy, Tobias
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 09.07.2023; MDPI
• Subjects: Amyotrophic lateral sclerosis; Atrophy; C9orf72 repeat expansion; Communication; Dementia; Disease; disease heterogeneity; DNA methylation; frontotemporal dementia (FTD); genetic variants; intermediate repeat length; Memory; Multiple sclerosis; multiple sclerosis (MS); Neurodegeneration; Pathogenesis; Patients; Spinal cord; Suicides & suicide attempts; genetic variants; multiple sclerosis (MS); frontotemporal dementia (FTD); intermediate repeat length; disease heterogeneity; C9orf72 repeat expansion
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms241411254

Multiple Sclerosis (MS) is a common immune-mediated disorder of the central nervous system that affects young adults and is characterized by demyelination and neurodegeneration. Recent studies have associated intermediate repeat expansions with MS. The objective of this study was to investigate whether repeat length is associated with MS or with a specific disease course in a monocentric Austrian MS cohort. Genotyping of 382 MS patients and 643 non-neurological controls for repeat expansions was performed. The study did not find a difference in the distribution of repeat numbers between controls and MS cases (median repeat units = 2; = 0.39). Additionally, sub-analysis did not establish a link between intermediate repeats and MS ( = 0.23) and none of the patients with progressive disease course carried an intermediate allele (20-30 repeat units). Exploratory analysis for different cut-offs (of ≥7, ≥17, and ≥24) did not reveal any significant differences in allele frequencies between MS and controls. However, the study did identify a progressive MS patient with a pathogenic expansion and probable co-existing behavioral variant frontotemporal dementia (bvFTD) in a retrospective chart review. In conclusion, this study did not find evidence supporting an association between repeat length and MS or a specific disease course in the Austrian MS cohort. However, the identification of a progressive MS patient with a pathogenic expansion and probable co-existing with FTD highlights the complexity and challenges involved in recognizing distinct neurodegenerative diseases that may co-occur in MS patients.